Amgen receives CHMP positive opinion for XGEVA(TM) (Denosumab) in the European Union
20 May 2011 | By Amgen
Amgen announced that the CHMP of the EMA has recommended a positive opinion for the marketing authorization of XGEVA™ (denosumab)...
List view / Grid view
20 May 2011 | By Amgen
Amgen announced that the CHMP of the EMA has recommended a positive opinion for the marketing authorization of XGEVA™ (denosumab)...
20 May 2011 | By Merck
Merck announced that the CHMP of the EMA has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS™...
20 May 2011 | By Cephalon Inc
The United States District Court for the District of Delaware granted a motion filed by plaintiffs Cephalon and Eurand for a TRO enjoining Mylan Pharmaceuticals and Mylan from manufacturing, using and selling its cyclobenzaprine hydrochloride extended-release capsules...
20 May 2011 | By Biogen Idec
Biogen Idec announced that FAMPYRA(R) (prolonged-release fampridine tablets) has been granted a positive opinion for conditional approval from the EMA's CHMP...
19 May 2011 | By Abbott
Results of the ACCORD Lipid study...
19 May 2011 | By Technology Strategy Board
The Technology Strategy Board and the MRC are to jointly invest over £3.7 million in seven major new research projects...
18 May 2011 | By Abbott
Abbott has received approval from the FDA to market its RealTime PCR test for measuring the viral load of hepatitis C...
18 May 2011 | By Pfizer
Pfizer Inc. announced data from the pivotal Phase 3 AXIS 1032 trial. Patients with previously treated advanced RCC, axitinib extended progression-free survival...
18 May 2011 | By OGILVY PR WORLDWIDE
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. announced results from a Phase 2b trial...
18 May 2011 | By AstraZeneca
AstraZeneca announced encouraging results from a phase II study in patients with platinum-sensitive relapsed serous ovarian cancer...
18 May 2011 | By ThromboGenics NV / BioInvent International AB
Two new studies now ongoing...
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the new Thermo Scientific Fiberlite LEX rotor series, combining lower rotor mass for superior ergonomics with outstanding performance and safety.
17 May 2011 | By Merck
Merck announced that it has entered into agreements with Roche...
17 May 2011 | By Merck
Transaction will strengthen Merck's development and commercialisationof pharmaceutical ophthalmic products...
17 May 2011 | By Novozymes Biopharma
New recombinant hyaluronic acid for eye care and ophthalmic drug delivery...